Analytical Challenges for Biological Drug Substances and Products - This conference is part of PharmaLab 2019

Analytical Challenges for Biological Drug Substances and Products - This conference is part of PharmaLab 2019

Düsseldorf/Neuss, Germany

Course No 200038


Costs

: EUR 590,--

(All prices excl. VAT)

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org

Programme

Regulatory Requirements of analytical procedure & validation
Dr Norbert Handler, RD&C Research, Development & Consulting

How to overcome some of the challenges when analysing Biological Drug Substances and Products
Thomas Fechner, Agilent

Analytical Quality by Design Through the Lifecycle
Patrick Jackson, GSK

State-of-the-Art evaluation of potency bioassays
Klemens Weitenthaler, VelaLabs – A Tentamus Company

Process for automatization of a Bioassay
Dr Marcus Gutmann, Microcoat Biotechnologie

Application of fast and non-destructive analysis techniques in quality and in-process control
Prof. Dr. Hartwig Schulz, formerly Julius Kühn-Institut (JKI)

Lectin Array – a novel technology for investigation of pharmaceutical products
Markus Roucka, VelaLabs – A Tentamus Company

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information

OK